New curcumin myeloma clinical trial

Conclusion: “Curcumin has an efficacy in improving overall remission and decreasing NF-kB, VEGF, TNF-a, and IL-6 levels in myeloma patients.” And so we have more proof…and this proof comes from actual myeloma patients, not from cells grown in a Petri dish. The evidence is piling up! I wonder when (or if!) our myeloma luminaries and organisations are going to wake up to the fact that curcumin has a real potential to help us myeloma folks at every stage of this cancer. If I could, I would tell them (the above luminaries and organisations) to ignore the profits and benefits (international conferences held in exotic locations, e.g.) they receive from the big pharmaceutical companies and to focus instead on us, their patients, and on our wellbeing. (Hah! Utopia, I know. Not going to happen…) It’s so frustrating to see no move in that direction. And so we must move on our own, for example by printing out these articles and giving them to our specialists. It’s going to be a slow process, that’s for sure…But I see no other way at present. We are the only ones who can push for a change… Well, I’m about to go on a lovely holiday with some of my favorite people in the world, so, to be honest, right now I want to think positive, happy thoughts and not go on a long rant about big Pharma and the obvious (financial) hold it has over the cancer system. So…enough. And now I have some packing to do, including putting my bottle ...
Source: Margaret's Corner - Category: Cancer & Oncology Authors: Tags: Blogroll curcumin myeloma clinical trial Source Type: blogs